The Medicines for Human Use (Clinical Trials) Regulations 2004 No. 1031

SCHEDULE 1 U.K. CONDITIONS AND PRINCIPLES OF GOOD CLINICAL PRACTICE AND FOR THE PROTECTION OF CLINICAL TRIAL SUBJECTS

[F1 PART 2 U.K. CONDITIONS AND PRINCIPLES WHICH APPLY TO ALL CLINICAL TRIALS

Textual Amendments

F1 Sch. 1 Pt. 2 substituted (29.8.2006) by The Medicines for Human Use (Clinical Trials) Amendment Regulations 2006 (S.I. 2006/1928), regs. 1(1), 27(2)

Conditions based on Article 3 of the Directive U.K.

14.   Provision has been made for insurance or indemnity to cover the liability of the investigator and sponsor which may arise in relation to the clinical trial.]